Bimzelx (bimekizumab)

pCPA File Number: 22719

Negotiation Status:

Under consideration for negotiation

Indication(s):

Psoriatic Arthritis

Sponsor/Manufacturer:

UCB Canada Inc.

CDA-AMC Project Number:

SR0803-000

pCPA Engagement Letter Issued:

Not Applicable

Negotiation Process Concluded:

Not Applicable